Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsCBI Pharmaceutical Congress on Paragraph IV Disputes
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
ADVERTISEMENTS
The Center for Business Intelligence (CBI) will be holding its Pharmaceutical Congress on Paragraph IV Disputes on October 15-16 in Philadelphia, PA. The conference will cover important issues for both brand and generic companies during two days of presentations and panel discussions on litigation strategies, statutory guidelines, current cases, and their landmark decisions. Topics to be discussed at the conference include: ? FTC address on pharmaceutical antitrust; ? In-depth analysis of recent court cases and their implications on brand and generic companies; ? Effects of KSR on brand and generic litigation strategies; ? Panel discussion on acceptable settlement strategies for...Full post as published by Patent Docs on August 09, 2008 (boomark / email).
Lawsuits and Settlements
Employment
Employee rights including labor law, harassment, safety, unpaid overtime, discrimination and union disputes.
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

CBI "Paragraph IV Disputes" Conference, Philadelphia, October 15-16
CBIs Pharmaceutical Congress on Paragraph IV Disputes
ACI "Paragraph IV Disputes" Conference, New York City, April 30-May 1
Mutual Pharmaceutical Jumps the Gun By Sending Paragraph IV Notice Letter Before Acceptance of ANDA
More and more domain name disputes
Watson Notified of OXYTROL(R) Patent Challenge









